Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 76026 - 76050 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Sucrose	Approved Investigational	HBEGF	1839	upregulated	Sucrose results in increased expression of HBEGF mRNA	5q31.3	A21896
Sulfamethoxazole	Approved Investigational	PHYH	5264	downregulated	Sulfamethoxazole results in decreased expression of PHYH mRNA	10p13	A20438
Sulfamethoxazole	Approved Investigational	PIR	8544	upregulated	Sulfamethoxazole results in increased expression of PIR mRNA	Xp22.2	A20663
Sulfaphenazole	Approved	CYP2C9	1559	downregulated	Sulfaphenazole results in decreased expression of CYP2C9 mRNA	10q23.33	A24341
Sulfapyridine	Approved Withdrawn	TIMP2	7077	upregulated	Sulfapyridine results in increased expression of TIMP2 mRNA	17q25.3	A20641
Sulfasalazine	Approved Investigational	CXCL8	3576	downregulated	Sulfasalazine results in decreased expression of CXCL8 mRNA	4q13.3	A24342 A24343 A24344
Sulfasalazine	Approved Investigational	CYP27B1	1594	downregulated	Sulfasalazine results in decreased expression of CYP27B1 mRNA	12q14.1	A24345
Sulfasalazine	Approved Investigational	ICAM1	3383	downregulated	Sulfasalazine results in decreased expression of ICAM1 mRNA	19p13.2	A24346
Sulfasalazine	Approved Investigational	IL1B	3553	downregulated	Sulfasalazine results in decreased expression of IL1B mRNA	2q14.1	A24342 A24344
Sulfasalazine	Approved Investigational	MICA	100507436	downregulated	Sulfasalazine results in decreased expression of MICA mRNA	6p21.33	A24347
Sulfasalazine	Approved Investigational	NR3C1	2908	upregulated	Sulfasalazine results in increased expression of NR3C1 mRNA	5q31.3	A24348
Sulfasalazine	Approved Investigational	TNFSF11	8600	downregulated	Sulfasalazine results in decreased expression of TNFSF11 mRNA	13q14	A23224
Sulfasalazine	Approved Investigational	TPM3	7170	downregulated	Sulfasalazine results in decreased expression of TPM3 mRNA alternative form	1q21.3	A20642
Sulfasalazine	Approved Investigational	TYMP	1890	downregulated	Sulfasalazine results in decreased expression of TYMP mRNA	22q13.33	A24343
Sulfasalazine	Approved Investigational	VCAM1	7412	downregulated	Sulfasalazine results in decreased expression of VCAM1 mRNA	1p21.2	A24346
Sulfinpyrazone	Approved	CYP3A4	1576	upregulated	Sulfinpyrazone results in increased expression of CYP3A4 mRNA	7q22.1	A21545 A20983 A21547
Sulfisoxazole	Approved Vet Approved	CYP3A4	1576	upregulated	Sulfisoxazole results in increased expression of CYP3A4 mRNA	7q22.1	A15703
Sulindac	Approved Investigational	ACP2	53	upregulated	Sulindac results in increased expression of ACP2 mRNA	11p11.2	A20927
Sulindac	Approved Investigational	AIF1L	83543	downregulated	Sulindac results in decreased expression of AIF1L mRNA	9q34.12-q34.13	A20927
Sulindac	Approved Investigational	AIFM2	84883	upregulated	Sulindac results in increased expression of AIFM2 mRNA	10q22.1	A20927
Sulindac	Approved Investigational	AKT2	208	downregulated	Sulindac results in decreased expression of AKT2 mRNA	19q13.2	A20927
Sulindac	Approved Investigational	ANKRD11	29123	upregulated	Sulindac results in increased expression of ANKRD11 mRNA	16q24.3	A20927
Sulindac	Approved Investigational	ARGLU1	55082	upregulated	Sulindac results in increased expression of ARGLU1 mRNA	13q33.3	A20927
Sulindac	Approved Investigational	ARRDC3	57561	upregulated	Sulindac results in increased expression of ARRDC3 mRNA	5q14.3	A20927
Sulindac	Approved Investigational	ASNS	440	upregulated	Sulindac results in increased expression of ASNS mRNA	7q21.3	A20927

Displaying entries 76026 - 76050 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability